Review

Methemoglobinemia: Pathogenesis, Diagnosis, and Management

Authors: Anna Skold, MD, MPH, Dominique L. Cosco, MD, Robin Klein, MD

Abstract

The diagnosis of methemoglobinemia should be considered in patients presenting with cyanosis and hypoxia. A variety of frequently used medications are capable of inducing methemoglobinemia, with dapsone and benzocaine being common culprits. Unique features, such as a saturation gap and chocolate-brown-colored blood, can raise suspicion for methemoglobinemia. Typically, symptoms correlate with the methemoglobin level, and treatment with methylene blue is reserved for patients with significantly elevated methemoglobin levels. In the presence of comorbid conditions that impair oxygen transport, however, low-grade methemoglobinemia can become symptomatic and may warrant treatment.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Mansouri A, Lurie AA. Concise review: methemoglobinemia. Am J Hematol 1993;42:7-12.
 
2. Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med 1999;34:646-656.
 
3. Curry S. Methemoglobinemia. Ann Emerg Med 1982;11:214-221.
 
4. Haymond S, Cariappa R, Eby CS, et al. Laboratory assessment of oxygenation in methemoglobinemia. Clin Chem 2005;51:434-444.
 
5. Ash-Bernal R, Wise R, Wright SM. Acquired methemoglobinemia. A retrospective series of 138 cases at 2 teaching hospitals. Medicine 2004;83:265-273.
 
6. Shadnia S, Rahimi M, Moeinsadat M, et al. Acute methemoglobinemia following attempted suicide by dapsone. Arch Med Res 2006;37:410-414.
 
7. Sin DD, Shafran SD. Dapsone and primaquine-induced methemoglobinemia in HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:477-481.
 
8. Falkenhahn M, Kannan S, O'Kane M. Unexplained acute severe methemoglobinaemia in a young adult. Br J Anaesth 2001;86:278-280.
 
9. Ferguson AJ, Lavery GG. Deliberate self-poisoning with dapsone. Anaesthesia 1997;52:359-363.
 
10. Ashurst JV, Wasson MN, Hauger W, et al. Pathophysiologic mechanisms, diagnosis, and management of dapsone-induced methemoglobinemia. J Am Osteopath Assoc 2010;110:16-20.
 
11. Moulis G, Bagheri H, Saint Martory J, et al. Very late relapse of dapsone-induced methaemoglobinemia. Eur J Clin Pharmacol 2010;66:645-646.
 
12. Turner MD, Karlis V, Glickman RS. The recognition, physiology, and treatment of medication-induced methemoglobinemia: a case report. Anesth Prog 2007;54:115-117.
 
13. Salamat A, Watson HG. Drug-induced methaemoglobinaemia presenting with angina following the use of dapsone. Clin Lab Haem 2003;25:327-328.
 
14. Walker JG, Kadia T, Brown L, et al. Dapsone induced methemoglobinemia in a patient with glioblastoma. J Neurooncol 2009;94:149-152.
 
15. Ward KE, McCarthy MW. Dapsone-induced methemoglobinemia. Ann Pharmacother 1998;32:549-553.
 
16. Williams S, MacDonald P, Hoyer JD, et al. Methemoglobinemia in children with acute lymphoblastic leukemia (ALL) receiving dapsone for Pneumocystis carinii pneumonia (PCP) prophylaxis: a correlation with cytochrome B5 reductase enzyme levels. Pediatr Blood Cancer 2005;44:55-62.
 
17. Guay J. Methemoglobinemia related to local anesthetics: a summary of 242 episodes. Anesth Analg 2009;108:837-845.
 
18. El-Husseini A, Azarov N. Is the threshold for treatment of methemoglobinemia the same for all? A case report and literature review. Am J Emerg Med 2010;28:e5-e10.
 
19. Kane GC, Hoehn SM, Behrenbeck TR, et al. Benzocaine-induced methemoglobinemia based on the mayo clinic experience from 28,478 transesophageal echocardiograms: incidence, outcomes, and predisposing factors. Arch Intern Med 2007;167:1977-1982.
 
20. Evelyn K, Malloy H. Microdetermination of oxyhemoglobin, methemoglobin, and sulfhemoglobin in a single sample of blood. J Biol Chem 1938;126:655.
 
21. Groeper K, Katcher K, Tobias JD. Anesthetic management of a patient with methemoglobinemia. South Med J 2003;96:504-509.
 
22. Clifton J, Leikin JB. Methylene blue. Am J Ther 2003;10:289-291.
 
23. Dunford LM, Roy DM, Hahn TE, et al. Dapsone-induced methemoglobinemia after hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2006;12:241-242.
 
24. Yu DR, Quinn TC. Symptomatic dapsone-induced methemoglobinemia in patients with HIV infection. Infect Dis Clin Pract 1996;5:511-513.
 
25. Schiff De, Roberts WD, Sue YJ. Methemoglobinemia associated with dapsone therapy in a child with pneumonia and chronic immune thrombocytopenia purpura. J Pediatr Hematol Oncol 2006;28:395-398.
 
26. Choi A, Sarang A. Drug-induced methaemoglobinaemia following elective coronary artery bypass grafting. Anesthesia 2007;62:737-740.